Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05097157 · ClinicalTrials.gov registry record · NA
Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 79
- Enrollment target
NCT05097157 is a NA study that has completed, run by Cynosure. The registered enrollment target is 79 participants.
The verdict
NCT05097157, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 79 participants
- Enrollment target
Study Summary
Subjects are to be enrolled in this clinical study if they are 18 - 55 years old. Up to 120 subjects will be enrolled at multiple study centers. Subjects may receive up to 5 treatments for a wide array of dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.
Interventions
- DEVICE Potenza
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2019-09-03 |
| Est. Completion | 2021-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05097157
The ClinicalTrials.gov registry entry for NCT05097157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Potenza is the first listed.
NCT05097157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05097157 about?
NCT05097157 is a clinical study titled "Study To Assess A Radiofrequency Microneedling Device For Dermatologic Conditions". Subjects are to be enrolled in this clinical study if they are 18 - 55 years old. Up to 120 subjects will be enrolled at multiple study centers. Subjects may receive up to 5 treatments for a wide array of dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for me...
What is the current status of trial NCT05097157?
This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2019-09-03. Estimated completion is 2021-06-21.
What interventions are being tested in trial NCT05097157?
The interventions under investigation include: Potenza (DEVICE).
Who is sponsoring clinical trial NCT05097157?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.